Home |
Free Dividend Report |
Stock Splits Calendar |
LBIO Historical Stock Prices |
Preferred Stock Newsletter |
LBIO Options Chain |
Stock Message Boards |
LBIO (LBIO) has the following price history information. Looking back at LBIO historical stock prices for the last five trading days, on June 21, 2017, LBIO opened at $6.60, traded as high as $6.75 and as low as $6.45, and closed at $6.65. Trading volume was a total of 667.70K shares. On June 22, 2017, LBIO opened at $6.75, traded as high as $6.85 and as low as $6.60, and closed at $6.70. Trading volume was a total of 641.40K shares. On June 23, 2017, LBIO opened at $6.65, traded as high as $7.45 and as low as $6.63, and closed at $7.35. Trading volume was a total of 2.39M shares. On June 26, 2017, LBIO opened at $7.35, traded as high as $7.50 and as low as $7.05, and closed at $7.15. Trading volume was a total of 681.50K shares. On June 27, 2017, LBIO opened at $7.20, traded as high as $7.20 and as low as $6.80, and closed at $6.95. Trading volume was a total of 501.20K shares.
LBIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into LBIO shares, starting with a $10,000 purchase of LBIO, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/22/2014 | |
End date: | 06/27/2017 | |
Start price/share: | $8.70 | |
End price/share: | $6.95 | |
Dividends collected/share: | $0.00 | |
Total return: | -20.11% | |
Average Annual Total Return: | -6.81% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,988.87 | |
Years: | 3.18 |
LBIO Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
06/21/2017 | $6.60 | $6.75 | $6.45 | $6.65 | 667.70K |
06/22/2017 | $6.75 | $6.85 | $6.60 | $6.70 | 641.40K |
06/23/2017 | $6.65 | $7.45 | $6.63 | $7.35 | 2.39M |
06/26/2017 | $7.35 | $7.50 | $7.05 | $7.15 | 681.50K |
06/27/2017 | $7.20 | $7.20 | $6.80 | $6.95 | 501.20K |
About LBIO |
Lion Biotechnologies is a development stage biotechnology company focused on developing and commercializing adoptive cell therapy (ACT) using autologous tumor infiltrating lymphocytes (TILs) for the treatment of metastatic melanoma and other solid cancers. ACT utilizes T-cells harvested from a patient to treat cancer in that patient. TIL are collected from individual patient tumor samples. The TIL are then activated and expanded ex vivo and then infused back into the patient to fight their tumor cells. Co.'s product pipeline includes: LN-144, which is for the treatment of metastatic melanoma; and LN-145, which is for the treatment of cervical and head and neck cancers. |
LBIO Historical Closing Prices | |
Date | Close |
06/21/2017 | $6.65 |
06/22/2017 | $6.70 |
06/23/2017 | $7.35 |
06/26/2017 | $7.15 |
06/27/2017 | $6.95 |
Healthcare Historical Prices |
LBIO is categorized under the Healthcare sector; below are some other companies in the same sector:
LBMH Historical Stock Prices
Free LBIO Email Alerts:
|
LBIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.